CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 35 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $76,000 | -85.6% | 51,992 | -80.7% | 0.04% | -35.5% |
| Q4 2019 | $529,000 | -61.7% | 270,017 | 0.0% | 0.06% | -65.0% |
| Q3 2019 | $1,382,000 | -20.3% | 270,017 | +11.5% | 0.18% | +47.5% |
| Q2 2019 | $1,734,000 | -28.9% | 242,200 | +31.8% | 0.12% | +6.2% |
| Q1 2019 | $2,440,000 | +149.5% | 183,800 | +47.9% | 0.11% | +68.7% |
| Q4 2018 | $978,000 | +3160.0% | 124,300 | +1000.0% | 0.07% | +1575.0% |
| Q2 2015 | $30,000 | -92.8% | 11,300 | -81.3% | 0.00% | -93.1% |
| Q1 2015 | $417,000 | – | 60,300 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,787,094 | $26,645,572 | 14.80% |
| Lynx1 Capital Management LP | 994,161 | $14,822,941 | 9.80% |
| Octagon Capital Advisors LP | 3,073,750 | $45,829,613 | 7.04% |
| Saturn V Capital Management LP | 1,124,459 | $16,765,684 | 7.02% |
| Altium Capital Management LP | 800,000 | $11,928,000 | 6.22% |
| Affinity Asset Advisors, LLC | 1,129,376 | $16,838,996 | 4.74% |
| ACUTA CAPITAL PARTNERS, LLC | 418,000 | $6,232,380 | 4.18% |
| Cormorant Asset Management, LP | 3,850,000 | $57,403,500 | 3.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 590,000 | $8,796,900 | 2.67% |
| MPM BioImpact LLC | 610,770 | $9,106,581 | 2.43% |